TABLE OF CONTENTS
Volume 15, Issue 1 (January 2008)
Original Articles
Regulated expression of the interferon-
gene in mice
R N Harkins, P Szymanski, H Petry, A Brooks, H S Qian, C Schaefer, P J Kretschmer, A Orme, P Wang, G M Rubanyi and T W Hermiston
Gene Ther 15: 1-11; advance online publication, July 19, 2007; doi:10.1038/sj.gt.3302998
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors
P W Raake, R Hinkel, S Müller, S Delker, R Kreuzpointner, C Kupatt, H A Katus, J A Kleinschmidt, P Boekstegers and O J Müller
Gene Ther 15: 12-17; advance online publication, October 18, 2007; doi:10.1038/sj.gt.3303035
Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer
V Russ, H Elfberg, C Thoma, J Kloeckner, M Ogris and E Wagner
Gene Ther 15: 18-29; advance online publication, October 25, 2007; doi:10.1038/sj.gt.3303046
Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice
F Shen, Y Fan, H Su, Y Zhu, Y Chen, W Liu, W L Young and G-Y Yang
Gene Ther 15: 30-39; advance online publication, October 25, 2007; doi:10.1038/sj.gt.3303048
Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function
H Zhang, S-J Zhu, W Wang, Y-J Wei and S-S Hu
Gene Ther 15: 40-48; advance online publication, October 18, 2007; doi:10.1038/sj.gt.3303049
Short Communications
The cHS4 chromatin insulator reduces gammaretroviral vector silencing by epigenetic modifications of integrated provirus
C L Li and D W Emery
Gene Ther 15: 49-53; advance online publication, November 8, 2007; doi:10.1038/sj.gt.3303009
Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice
H Petry, A Brooks, A Orme, P Wang, P Liu, J Xie, P Kretschmer, H S Qian, T W Hermiston and R N Harkins
Gene Ther 15: 54-60; advance online publication, October 25, 2007; doi:10.1038/sj.gt.3303037
DNA, but not protein vaccine based on mutated BORIS antigen significantly inhibits tumor growth and prolongs the survival of mice
M Mkrtichyan, A Ghochikyan, D Loukinov, H Davtyan, T E Ichim, D H Cribbs, V V Lobanenkov and M G Agadjanyan
Gene Ther 15: 61-64; advance online publication, November 1, 2007; doi:10.1038/sj.gt.3303044
Corrigendum
Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer FREE
D Hoffmann, J M Bangen, W Bayer and O Wildner
Gene Ther 15: 65; doi:10.1038/sj.gt.3303083
Erratum
A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer FREE
A Riezebos-Brilman, M Walczak, J Regts, M G Rots, G Kamps, B Dontje, H Y Haisma, J Wilschut and T Daemen
Gene Ther 15: 66; doi:10.1038/sj.gt.3303084
